Paula Ragan - 13 Feb 2024 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Signature
/s/ Adam S. Mostafa, attorney-in-fact
Issuer symbol
XFOR
Transactions as of
13 Feb 2024
Transactions value $
$0
Form type
4
Filing time
16 Feb 2024, 17:09:27 UTC
Previous filing
12 Feb 2024
Next filing
11 Mar 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XFOR Stock Appreciation Right Award $0 +1.19M $0.00 1.19M 13 Feb 2024 Common Stock 1.19M $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of February 13, 2024, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.